The Hidden Price of Not Doing the Right Thing

Hatched by Gerold

Jul 15, 2026

10 min read

1 views

84%

The Question Behind the Bill

Why does something that should feel simple, like getting care when you are sick, become so hard to afford? Most people answer with a list of usual suspects: greedy corporations, broken insurance, administrative bloat, or expensive technology. Those factors matter. But they do not reach the deeper problem.

The more unsettling question is this: what happens when a system no longer has a trustworthy moral center?

In health care, prices are not just numbers. They are signals of power, fear, bargaining leverage, and moral drift. When hospitals, doctors, and pharmaceutical companies decide what to charge, the issue is not merely that prices are high. It is that the market has become a place where the ordinary restraint that should govern human vulnerability has weakened. A sick person is not choosing a luxury item. A patient is standing at a threshold where need is immediate, information is asymmetric, and delay can be costly or fatal. In that setting, price is never just price.

The phrase do the right thing often sounds like a schoolroom lesson, almost too simple for a trillion dollar economy. But simplicity is the point. Many of our biggest social failures begin when actors stop asking a basic question: is this charge, this policy, this incentive, this profit acceptable if my own family were on the receiving end?

Health care in America is expensive not only because the system is complex, but because too many of its decisions have been detached from that question.

When the Market Meets Human Fragility

A normal market works best when buyers can compare options, wait, walk away, or substitute. If a coffee shop raises prices, customers can choose another café, brew at home, or simply go without. That freedom disciplines the seller. Health care often removes those exits.

If you are in pain, you do not shop calmly. If your child needs treatment, you do not negotiate from a position of strength. If you need a specialty drug, a hospital procedure, or a surgeon in a narrow window of time, your leverage is thin. This means the “price” of care is partly shaped by the absence of real consent. You may technically agree, but agreement under duress is not the same as a free exchange.

That is why a 10 year tripling in specialty drug prices is not just an economic statistic. It is a moral alarm bell. Specialty medicines are often lifesaving, often for chronic or serious conditions, and often unavailable in meaningful substitutes. When their costs explode, the system is not merely redistributing money. It is converting desperation into revenue.

Here is the deeper pattern: whenever a system becomes difficult to refuse, it becomes vulnerable to extraction. Airlines can charge more for baggage. Software can raise subscription fees. But medicine sits in a different category because the buyer is not purchasing convenience. The buyer is purchasing time, mobility, relief, and sometimes survival.

The more essential the good, the less meaningful pure market language becomes.

That is why debates about health care cost often feel circular. People keep asking whether the system is efficient, but the more urgent question is whether it is morally legible. Can a patient, worker, clinician, or insurer explain the logic of the bill without feeling that something basic has been violated?

The Real Scarcity Is Not Medicine, It Is Restraint

High prices are usually explained as the result of scarcity. There is not enough supply, too much demand, too much regulation, too little competition. Those explanations can be true in parts. But they often miss the most important scarcity in American health care: restraint.

Restraint means the willingness to limit what you can extract because another person is vulnerable. It is what keeps a landlord from charging whatever the market will bear in a fire. It is what keeps a teacher from monetizing every hour of a child’s attention. It is what keeps a doctor from treating every diagnosis like an upsell opportunity.

In a healthy system, restraint shows up in several places:

Pricing restraint, where charges reflect reasonable value rather than maximum capture.
Institutional restraint, where hospitals and pharma companies accept that being essential creates obligations.
Professional restraint, where clinicians protect patients from unnecessary tests, procedures, and costs.
Policy restraint, where rules prevent actors from benefiting from confusion, urgency, or asymmetry.

When restraint disappears, the system begins to monetize its own moral authority. It charges not only for the service, but for the fact that the service is hard to refuse.

This is one reason people feel that health care feels unlike other industries. A grocery store can make money without asking you to trust it with your body. A health system cannot. It asks for trust, then often responds with a bill that seems to deny the very trust it requested.

That breach matters more than many analysts admit. Once people sense that a system is using their vulnerability as a pricing opportunity, every interaction becomes suspect. Trust declines, compliance weakens, and costs can rise further as patients delay care, skip medications, or pursue fragmented alternatives. The damage is not only financial. It is psychological and civic.

The system becomes a place where the vulnerable learn to expect exploitation.

A Better Lens: The Ethics of Price Under Dependence

We need a better framework than “what does the market allow?” for services where the buyer is deeply dependent on the seller. One useful lens is this: the more asymmetric the relationship, the more ethically constrained the price must be.

This idea is intuitive in other areas of life. We do not think it is acceptable to charge emergency evacuees whatever they can pay when a bridge collapses. We do not think it is acceptable for a prison commissary to operate like a luxury boutique. We do not think it is acceptable for a landlord to double rent during a disaster. Why? Because dependence changes the moral meaning of exchange.

Health care lives permanently inside that condition of dependence.

That does not mean every service should be free or that all profits are suspect. It means that the question of price cannot be separated from the question of power. A fair price is not just one that can be defended in a spreadsheet. It is one that can be defended in the presence of the person who must pay it, knowing they had limited ability to refuse.

This also helps explain why the health care debate gets stuck in blame wars. Insurers blame providers. Providers blame insurers. Pharma blames research costs and risk. Policymakers blame the market. Each side may have a partial case, but the pattern of blame hides a larger failure: everyone is participating in a system that rewards the erosion of restraint.

A morally serious system would ask different questions.

Does this price reflect genuine value, or just leverage?
Does this margin fund innovation, or merely amplify exclusion?
Does this billing practice inform patients, or confuse them?
Does this negotiation protect care, or transform illness into a profit center?

These are not just ethical questions. They are design questions. A system built without them will eventually treat suffering as a business model.

Doing the Right Thing Is Not Naive, It Is Infrastructure

People often say that “doing the right thing” is admirable but unrealistic. That usually means they believe morality is a nice supplement to serious policy, not a foundation for it. But in health care, ethics is not decoration. It is infrastructure.

Why? Because trust lowers transaction costs, reduces defensive behavior, improves adherence, and makes coordination possible. A patient who believes the system is trying to help is more likely to share information honestly, follow treatment, and seek care early. A clinician who feels supported is less likely to practice cynical medicine. A hospital that prioritizes long term legitimacy over short term extraction creates a more stable ecosystem.

In this sense, doing the right thing is not the opposite of efficiency. It is one of the conditions for efficiency.

Think of a bridge. It is expensive not only because steel is costly, but because the structure must bear weight safely over time. The cheapest bridge is useless if it collapses. Health care works the same way. The cheapest billing scheme is not the most efficient if it drives patients away, produces distrust, or forces families into financial ruin.

This is why the specialty drug price explosion should be read as a systems failure, not only a pricing problem. A 52,000 dollar annual price tag does not merely reflect value. It reflects a political economy where essential treatment can become a luxury asset. At that point, the market has stopped behaving like a market for ordinary goods and started behaving like a tollbooth on the road to survival.

When a system can profit from the fact that you cannot meaningfully say no, it has crossed from commerce into coercion.

That is the real danger. Not that prices are high in the abstract, but that they become disconnected from any shared sense of obligation.

What a More Humane System Would Measure

If restraint is scarce, the obvious solution is not just more outrage. We need metrics that reward the right behavior.

A humane health care system would not only track profits, utilization, and margins. It would track burden. How much of a patient’s annual income does a treatment absorb? How often are patients forced to choose between medication and rent? How many bills are incomprehensible until they arrive in collections? How often are people denied needed care because the price was technically legal but practically impossible?

These are not side issues. They are the moral equivalents of emissions in an industrial economy. If a factory can pollute for free, it will. If a health system can externalize pain, stress, and bankruptcy onto families, it will too.

A better system would also distinguish between three different kinds of cost:

Value cost: what genuinely improves outcomes.
Waste cost: what pays for inefficiency, duplication, or administration.
Vulnerability tax: what is charged simply because the buyer has no good alternative.

That third category is the most revealing. It is the hidden surcharge on being sick.

Once you see it, many things look different. A confusing bill is not just an administrative annoyance. It is a vulnerability tax. A sudden specialty drug increase is not just inflation. It is a vulnerability tax. A hospital charge that bears little relation to the service delivered is often a vulnerability tax with a better suit on.

Naming this matters because what we measure, we eventually manage. If the system only measures revenue, it will optimize revenue. If it measures burden, dignity, and access, it will be forced to answer to something larger than itself.

Key Takeaways

High health care prices are not only an economic problem, they are a moral signal. When care becomes expensive in a system built on dependence, it often reveals a failure of restraint.
The less freedom a buyer has, the more ethically constrained the seller should be. This is why health care cannot be judged by ordinary market logic alone.
“Doing the right thing” is not sentimental, it is system design. Trust, transparency, and restraint reduce hidden costs and improve outcomes.
Track vulnerability, not just revenue. Ask how much illness costs families in stress, debt, delay, and lost options, not merely in dollars on a balance sheet.
A fair price is one you could defend in front of the person who must pay it. If the logic sounds reasonable only when hidden inside complexity, that is a warning sign.

The Price of a Civilization Is What It Charges the Sick

The most revealing measure of a society is not how it treats the powerful, but how it prices the vulnerable. In health care, that test is repeated every day. A patient arrives hoping for relief and instead enters a maze of charges, codes, negotiations, and fine print. At that moment, the system makes a statement about what kind of community it is.

If we want lower costs, we will need better policy, better competition, and better incentives. But beneath all of that, we will need something simpler and harder: a renewed commitment to restraint when people are least able to protect themselves.

That is what “do the right thing” really means in a system like this. Not moral theater. Not vague virtue. A discipline of saying, this is essential, this is fragile, and therefore this is not the place to extract everything the market will bear.

The real issue is not just that health care is expensive. It is that we have allowed the logic of pricing to outrun the ethics of care. And once that happens, the bill is no longer only financial. It is a measure of how far a society has drifted from its own conscience.